3eo9: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:3eo9.png|left|200px]] | [[Image:3eo9.png|left|200px]] | ||
| Line 20: | Line 19: | ||
==About this Structure== | ==About this Structure== | ||
[[3eo9]] is a 2 chain structure of [[Monoclonal Antibody]] with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3EO9 OCA]. | |||
==See Also== | |||
*[[Monoclonal Antibody]] | |||
==Reference== | ==Reference== | ||
| Line 31: | Line 33: | ||
[[Category: Fab]] | [[Category: Fab]] | ||
[[Category: Immune system]] | [[Category: Immune system]] | ||
Revision as of 20:19, 26 December 2010
Crystal structure the Fab fragment of Efalizumab
Template:ABSTRACT PUBMED 19258452
About this Structure
3eo9 is a 2 chain structure of Monoclonal Antibody with sequence from Homo sapiens. Full crystallographic information is available from OCA.
See Also
Reference
- Li S, Wang H, Peng B, Zhang M, Zhang D, Hou S, Guo Y, Ding J. Efalizumab binding to the LFA-1 alphaL I domain blocks ICAM-1 binding via steric hindrance. Proc Natl Acad Sci U S A. 2009 Mar 17;106(11):4349-54. Epub 2009 Mar 3. PMID:19258452
